Under the agreement, Burnham will gain access to Leap and Cyntellect will gain certain commercial rights to discoveries under the collaboration.
The collaboration efforts will focus on developing applications of Leap for automated purification of stem cells, stem cell colonies and the differentiated cells derived from stem cells.
Cyntellect and Burnham expect these new applications will accelerate discovery of new knowledge of stem cell differentiation factors and pathways, as well as generate cell populations that may be used to deliver the potential therapeutic benefits of stem cells.
Leap is said to be an automated live cell analysis and processing system that combines high-speed optical imaging (brightfield or fluorescence) and real-time image analysis with high-speed in situ laser manipulation of cells.